Written by Julia Rostova
3M delivered the sort of quarter that forces investors to treat the turnaround as more than a restructuring narrative. The company reported Q2 GAAP sales of $6.5 billion, adjusted sales of $6.5 billion with organic growth of 5.4%, adjusted operating margin of 24.9%, adjusted EPS of $2.40, and raised its full-year 2026 adjusted EPS guidance to $8.80-$8.95. For a business that spent years being framed primarily around litigation overhangs, portfolio clean-up, and skepticism about growth quality, those numbers matter. They suggest that 3M is moving back toward the category of industrial franchise that deserves to be analyzed on operating performance rather than merely on remediation progress.
The investment question is whether the stock still offers meaningful upside after that rehabilitation has become visible. On Finviz, MMM trades at $170.76 against a consensus target price of $185.53, implying only about 8.6% upside. The stock changes hands at 30.32x trailing earnings and 17.60x forward earnings, with 3.54x sales and a strikingly high 29.31x book multiple, alongside 20.57% operating margin and 11.90% profit margin. My verdict on MMM is HOLD with a $185 price target. The business looks healthier, but the stock no longer feels obviously mispriced.
| Stock | Current price | Verdict | Price target |
| MMM | $170.76 | HOLD | $185 |
| HON | $232.99 | HOLD | $253 |
| ITW | $273.93 | SELL | $275 |
The bull case for 3M rests on operational credibility. Mid-single-digit organic growth, strong adjusted margin performance, and raised guidance show that management is not merely cutting around the edges. It is improving the earnings shape of the business. That matters because investors are often willing to re-rate an industrial franchise once they believe the company can produce stable growth and disciplined margins without relying on financial engineering or temporary pricing noise.
3M’s quarter fits that pattern. The improvement suggests the business is regaining internal coherence, which is often what separates a genuine turnaround from a brief relief rally. The market clearly sees some of that already, but the stock’s moderate implied upside indicates that a meaningful part of the rehabilitation story is now in the price.
Honeywell is a useful comparison because it represents another high-quality industrial platform, though with a somewhat different portfolio mix. HON trades at $232.99 against a $253.35 target price, implying 8.7% upside. It carries a 16.51x P/E, 23.46x forward P/E, 1.86x sales, and 5.43x book, with 19.56% operating margin and 11.37% profit margin. My verdict on HON is HOLD with a $253 price target. It remains a solid industrial franchise, but at current levels the upside profile is similarly restrained.
Illinois Tool Works looks the most fully priced of the trio. ITW trades at $273.93 versus a $284.77 target price, implying only 4.0% upside. The stock carries a 25.43x P/E, 22.58x forward P/E, 4.86x sales, and 24.41x book, with an excellent 26.42% operating margin and 19.32% profit margin. Those are elite quality numbers, but they also mean investors are already paying heavily for them. My verdict on ITW is SELL with a $275 price target. This is not because the business is weak. It is because the valuation leaves too little margin for error.
| Company | P/E | Forward P/E | P/S | P/B | Oper. Margin | Profit Margin | Implied upside to consensus target | Reading |
| 3M | 30.32x | 17.60x | 3.54x | 29.31x | 20.57% | 11.90% | 8.6% | Turnaround is real, but valuation no longer offers easy asymmetry |
| Honeywell | 16.51x | 23.46x | 1.86x | 5.43x | 19.56% | 11.37% | 8.7% | Balanced franchise with modest upside, not an obvious bargain |
| Illinois Tool Works | 25.43x | 22.58x | 4.86x | 24.41x | 26.42% | 19.32% | 4.0% | Excellent business, but the stock looks the most stretched |
The risk to 3M is straightforward. Turnarounds often look cleanest just after confidence begins to recover. If growth slips, if margin resilience weakens, or if legal and portfolio baggage returns to the center of investor attention, the market may stop paying for the improved story. A recovering industrial is still different from a pristine secular grower.
This is where the capacity-to-suffer framework matters. 3M now looks more like a quality franchise temporarily suffering through a long repair than a permanently broken thesis. That deserves more patience than the market gave it in its darkest period. But patience does not mean indiscriminate optimism. Once much of the repair is recognized, the return opportunity becomes more moderate.
My conclusion is clear. MMM is a HOLD at $185 because the business is improving, but the stock already reflects much of that progress. HON is a HOLD at $253 because it offers a similar quality profile with similarly limited upside. ITW is a SELL at $275 because the operational excellence is real, but the valuation looks too tight. 3M has done the hard work of restoring credibility. The easy money, however, has largely already been made.
*This article is for informational and educational purposes only and is not financial advice. Investors should do their own due diligence, consider their risk tolerance, and remember that past performance does not guarantee future results.*
